|
 |
Investment Report of China Medical Industry, 2000-2008
|
 
China is the largest country in the world in terms of population. Its population of 1.3 billion people provides a huge market for the development of China's medical service industry. The existing medical resources are far from being able to satisfy people's demand, which results in the problems to be difficult and expensive to see a doctor. However, China's non-public medical service industry is underdeveloped seriously. So China has put forward the ideas to develop medical and health service system by actively introducing non-public funds, which provides a great opportunity for the development of China's non-public medical service industry.
From Jan. to Nov. 2007, the total industrial output value of China's medical instrument and apparatus manufacturing industry hit CNY51.446 billion, up 21.42% against the same period of the previous year, while the accumulated sales revenue and accumulated profit reached CNY49.32 billion and CNY5.26 billion, up 22.17% and 42.51% year on year respectively. In the next few years, China will surpass Japan and become the second largest medical instrument market in the world. The total output value of China's medical instruments and apparatus industry will reach CNY100 billion in 2010, taking up 5% share in the world's medical instruments and apparatus market.
This report makes an in-depth analysis on all investment projects financed by 18 listed companies, covering medical apparatus producers, medical service providers and pharmaceutical producers with investment in medical instruments, from 2000 to 2008 and also makes summary of investment trends of China's medical industry as well as investment features and investment trends of the listed companies.
The following chart shows that Shanghai has the biggest investment in medical projects by taking up 22.72% share of the national total, followed by Hubei province, Jiangxi province, Beijing and Zhejiang province.
Investment Distribution of China Listed Medical Companies (by Region), 2000-1H2008
Resource: ResearchInChina
Among the 18 listed companies, Shanghai Pharmaceutical Co. Ltd. ranks first in terms of investment amount from the year of 2000 to the first half of 2008 with a total amount of CNY2.55 billion, followed by Wuhan Humanwell Hi-tech Industry Co., Ltd. and Chengzhi Shareholding Co., Ltd.
Top 10 Companies in Terms of Investment, 2000-1H2008
Resource: ResearchInChina
This report makes an in-depth analysis on all investment projects financed by the 18 listed companies. For example, Shanghai Pharmaceutical Co., Ltd. (600849) is referred in this report.
Investment Distribution of Shanghai Pharmaceutical Co. (by Sector), 2000-2008
Resource: ResearchInChina
Investment of Shanghai Pharmaceutical Co., 2001-2007Year Investment Amount (CNY million)
Investment Features of Shanghai Pharmaceutical Co., Ltd
- Main Business: production, distribution and retail of traditional Chinese medicine and western medicine; diversification direction: pharmaceutical logistics industry.
- The company has kept a high investment amount for many years. Its investment hit CNY625 million in 2004, which is the highest record of this company. In the past four years, its investment was mainly financed by non fund raising. Its investment is concentrated in East China.
- The company is one of the three giants in China's pharmaceutical distribution industry. Medicine distribution is its highlight, covering more than 3,900 hospitals across China with sales of more than CNY9 billion. With the help of its strategy of international development, the company together with SUZUKEN Co., Ltd., a world leader in pharmaceutical distribution, has set up a joint venture engaged in pharmaceutical distribution. It has also signed OEM agreement with American Perrigo Company (NASDAQ: PRGO) regarding seven varieties of products and the commitment of 2.1 billion pieces a year, which is hopeful to reach three billion pieces annually. As for pharmaceutical logistics, the company has built a logistics center with an annual throughput of CNY15 billion.
Note: When you purchase this report, we can update the data to the most recent quarter.
1. Investment Direction of Medical Apparatus & Medical Service Industry
1.1 Overview of the industry
1.2 Investment Features
1.3 Development Trend
2. Investment Direction of Listed Medical Service Companies
2.1 Investment Projects of Chengzhi Shareholding Co., Ltd.
2.1.1 Investment Direction
2.1.2 Investment Features
2.2 Investment Projects of Chang An Information Industry (Group) Co., Ltd.
2.2.1 Investment Direction
2.2.2 Investment Features
2.3 Investment Projects of Beijing Tongche Medical Investment Co., Ltd.
2.3.1 Investment Direction
2.3.2 Investment Features
3. Investment Direction of Listed Medical Instrument Companies
3.1 Investment Projects of Shandong Pharmaceutical Glass Co., Ltd.
3.1.1 Investment Direction
3.1.2 Investment Features
3.2 Investment Projects of Suzhou Well Technology Co., Ltd.
3.2.1 Investment Direction
3.2.2 Investment Features
3.3 Investment Projects of Beijing Wandong Medical Equipment Co., Ltd.
3.3.1 Investment Direction
3.3.2 Investment Features
3.4 Investment Projects of Shandong Shinva Medical Instrument Co., Ltd.
3.4.1 Investment Direction
3.4.2 Investment Features
3.5 Investment Projects of Leading S&T Co., Ltd.
3.5.1 Investment Direction
3.5.2 Investment Features
3.6 Investment Projects of Wuhan Humanwell Hi-tech Industry Co., Ltd.
3.6.1 Investment Direction
3.6.2 Investment Features
3.7 Investment Projects of Yuyue Medical Equipment Co., Ltd.
3.7.1 Investment Direction
3.7.2 Investment Features
4. Investment Direction of Listed Pharmaceutical Companies with Investment in Medical Instruments
4.1 Investment Projects of Shanghai Pharmaceutical Co., Ltd.
4.1.1 Investment Direction
4.1.2 Investment Features
4.2 Investment Projects of Zhejiang Zhenyuan Co., Ltd.
4.2.1 Investment Direction
4.2.2 Investment Features
4.3 Investment Projects of Accord Pharmaceutical Co., Ltd.
4.3.1 Investment Direction
4.3.2 Investment Features
4.4 Investment Projects of China National Medicines Corporation Ltd.
4.4.1 Investment Direction
4.4.2 Investment Features
4.5 Investment Projects of Shanghai No.1 Pharmacy Co., Ltd.
4.5.1 Investment Direction
4.5.2 Investment Features
4.6 Investment Projects of Nanjing Pharmaceutical Co., Ltd.
4.6.1 Investment Direction
4.6.2 Investment Features
4.7 Investment Projects of Chongqing Tongjunge Pharmaceutical Factory Co., Ltd.
4.7.1 Investment Direction
4.7.2 Investment Features
4.8 Investment Projects of Hangzhou Huadong Medicine Group Co., Ltd.
4.8.1 Investment Direction
4.8.2 Investment Features
Annual Investment of China Listed Medical Companies, 2000-2008
Investment Distribution of China Listed Medical Firms (by region), 2000-1H2008
Top 10 Regions in Terms of Investment of China Listed Medical Firms, 2000-2008
Investment Distribution of China Listed Medical Firms (by Region), 2000-1H2008
Top 10 Companies in Terms of Investment (by Investment Purpose), 2000-2008
Top 10 Firms in Terms of Investment Distribution (by Purpose), 2000-1H2008
Investment of China Listed Medical Firms by Segmented Industry, 2000-2008
Investment Distribution of Listed Firms by Segmented Industry, 2000-1H2008
Top 10 Companies in Terms of Investment, 2000-1H2008
Investment by Non Fund Raising of China Listed Medical Firms, 1Q2006-2Q2008
Investment by Non Fund Raising of Listed Firms by Region, 1Q2006-2Q2008
Top 5 Regions in Terms of Non Fund Raising Investment, 1Q2006-2Q2008
Top 5 Companies in Terms of Non Fund Raising Investment, 1Q2006-2Q2008
Top 5 Firms in Terms of Non Fund Raising Investment (by Segmented Industry),
1Q2006-2Q2008
Annual Investment of Chengzhi Shareholding Co., Ltd., 2000-2008
Chengzhi Investment Distribution by Region, 2000-2008
Chengzhi Investment Distribution by Investment Purpose, 2000-2008
Chengzhi Investment by Main Investment Purpose, 2000-2008
Chengzhi Investment Distribution by Segmented Industry, 2000-2008
Chengzhi Investment by Main Segmented Industry, 2000-2008
Chengzhi Main Investment Projects, 2000-2008
Chengzhi Latest Investment Projects, 2000-2008
Chengzhi Main M&A Projects, 2000-2008
Annual Investment of Chang An Information Industry (Group) Co., 2000-2008
Chang An Investment Distribution by Region, 2000-2008
Chang An Investment Distribution by Investment Purpose, 2000-2008
Chang An Investment by Main Investment Purpose, 2000-2008
Chang An Investment Distribution by Segmented Industry, 2000-2008
Chang An Investment by Main Segment Industry, 2000-2008
Chang An Main Investment Projects, 2000-2008
Chang An Latest Investment Projects, 2000-2008
Chang An Main M&A Projects, 2000-2008
Annual Investment of Beijing Tongche Medical Investment Co., 2000-2008
Beijing Tongche Investment Distribution by Region, 2000-2008
Beijing Tongche Investment Distribution by Investment Purpose, 2000-2008
Beijing Tongche Investment by Main Investment Purpose, 2000-2008
Beijing Tongche Investment Distribution by Segmented Industry, 2000-2008
Beijing Tongche Investment by Main Segmented Industry, 2000-2008
Beijing Tongche Main Investment Projects, 2000-2008
Beijing Tongche Latest Investment Projects, 2000-2008
Beijing Tongche Main M&A Projects, 2000-2008
Annual Investment of Shandong Pharmaceutical Glass Co., Ltd., 2000-2008
SPGC Investment Distribution by Region, 2000-2008
SPGC Investment Distribution by Investment Purpose, 2000-2008
SPGC Investment by Main Investment Purpose, 2000-2008
SPGC Investment Distribution by Segmented Industry, 2000-2008
SPGC Investment by Main Segmented Industry, 2000-2008
SPGC Main Investment Projects, 2000-2008
SPGC Latest Investment Projects, 2000-2008
SPGC Main M&A Projects, 2000-2008
Annual Investment of Suzhou Well Technology Co., Ltd., 2000-2008
Suzhou Well Investment Distribution by Region, 2000-2008
Suzhou Well Investment Distribution by Investment Purpose, 2000-2008
Suzhou Well Investment by Main Investment Purpose, 2000-2008
Suzhou Well Investment Distribution by Segmented Industry, 2000-2008
Suzhou Well Investment by Main Segmented Industry, 2000-2008
Suzhou Well Main Investment Projects, 2000-2008
Suzhou Well Latest Investment Projects, 2000-2008
Suzhou Well Main M&A Projects, 2000-2008
Annual Investment of Beijing Wandong Medical Equipment Co., Ltd., 2000-2008
Wandong Medical Investment Distribution by Region, 2000-2008
Wandong Medical Investment Distribution by Investment Purpose, 2000-2008
Wandong Medical Investment by Main Investment Purpose, 2000-2008
Wandong Medical Investment Distribution by Segmented Industry, 2000-2008
Wandong Medical Investment by Main Segmented Industry, 2000-2008
Wandong Medical Main Investment Projects, 2000-2008
Wandong Medical Latest Investment Projects, 2000-2008
Wandong Medical Main M&A Projects, 2000-2008
Annual Investment of Shandong Shinva Medical Instrument Co., Ltd., 2000-2008
Shinva Medical Investment Distribution by Region, 2000-2008
Shinva Medical Investment Distribution by Investment Purpose, 2000-2008
Shinva Medical Investment by Main Investment Purpose, 2000-2008
Shinva Medical Investment Distribution by Segmented Industry, 2000-2008
Shinva Medical Investment by Main Segmented Industry, 2000-2008
Shinva Medical Main Investment Projects, 2000-2008
Shinva Medical Latest Investment Projects, 2000-2008
Shinva Medical Main M&A Projects, 2000-2008
Annual Investment of Leading S&T Co., Ltd., 2000-2008
Leading S&T Investment Distribution by Region, 2000-2008
Leading S&T Investment Distribution by Investment Purpose, 2000-2008
Leading S&T Investment by Main Investment Purpose, 2000-2008
Leading S&T Investment Distribution by Segmented Industry, 2000-2008
Leading S&T Investment by Main Segmented Industry, 2000-2008
Leading S&T Main Investment Projects, 2000-2008
Leading S&T Latest Investment Projects, 2000-2008
Leading S&T Main M&A Projects, 2000-2008
China Animal Vaccine Industry Report, 2009-2010 China’s animal vaccine market has grown up steadily despite all the twists and turns in the livestock and poultry breeding market over the past four years. In 2009, the market scale reached around RMB... Global and China Medical Devices Industry Report, 2009 The development of medical devices industry differs afar in developed countries and developing countries. In emerging markets like China and India, it is the economic growth that drives the expansion ... China Medical Sales and Medical Device Market Report, 2008 In the recent years, Chinese medical device market developed rapidly. During Jan to Nov 2008, 915 medical device companies were together realized a sales revenue of CNY 63.6 billion, accounting for 9.... China Diagnostic Reagent Market Report, 2007-2009 China's diagnostic reagent industry had lagged behind other countries for a long time. Since 1980s, China's reagent for clinical diagnosis has started entering the industrialization process, following... China Portable Medical Devices Report, 2007-2008 In 2007, the market scale of portable medical devices in China was CNY 24.56 billion, up by 16.5% year on year, which was mainly contributed by the purchase growth from large hospitals.
China ... Investment Report of China Medical Industry, 2000-2008 China is the largest country in the world in terms of population. Its population of 1.3 billion people provides a huge market for the development of China's medical service industry. The existing medi... Company Study of Huadong Medicine Huadong Medicine Co., Ltd. was founded in March, 1993, based on the medicine distribution network in Hanzhou, capital of Zhejiang province, after a government-oriented restructuring. On December 22, 1... China Medical Device Industry and Listed Company Report, 2008 China is a large medical apparatus and instruments producer in both Asia and the world. China, as one of the top ten emerging markets in the world's medical apparatus and instruments industry, had a m... Political Influence Study of China Medical Industry, 2007 China started the cut down the medicine price dramatically for the 21st time in Jan, 2007, and the management board also stated that it will continue to squeeze the medicine price foams for many times... China Medical Devices Market Report, 2007 Presently, the global sales revenue of medical device amounted to about USD 250 billion. Developed countries and regions take the majority of market shares, among which America takes 40%, Europe 30%, ... Company Study of Jiangsu Hengrui Medicine Jiangsu Hengrui Medicine Co., Ltd. mainly produces anti-tumor drugs, anti-infectious drugs, antibiotic drugs and drugs for operation, and the first kind generates most of the company's profit. In the ... China Medicated Health Product Industry Report, 2007 It's estimated that in the forthcoming couple of years, the growth rate of the sales income of the medical industry will remain at 15-17%. In the long term, thanks to the highest growth speed, China's... China Medical Industry Report, 2007 In the first quarter of 2007, the main business income of the whole medical manufacturing industry increased steadily, and growth margin of total profit exceeded 10% of the main business income. In ad... China Medical Sales Channel Report, 2006-2007 In the first three quarters of 2006, the total sales value of top seven medicine merchandises in China amounted to RMB 211.838 billion, up by 8.07% year-on-year, among which, the total sales value of ... China Medical Device Industry Report, 2005-2006 By the end of Dec 2005, the total assets of China medical device industry has reached RMB33.856 billion, in Q4 2005, the sales revenue of China medical device industry was RMB10.429 billion, increased... China Medical Devices Market Report, 2005 According to HIMA forecast, global medical instrument sales will reach $260 billion in 2006. The US medical instrument growth rate maintained at 9 percent.
According to the forecast of the 10th five... China Woundcare Products: Supplier Capability Report, 2005 China is poised to become one of the world’s largest exporters of woundcare products. Their market share is expected to increase further as suppliers boost production, gain CE marking and FDA approval... China Medical Imaging: Supplier Capability Report, 2005 China is poised to be a large exporter of medical imaging equipment in the world. Their market share is expected to increase further as suppliers boost production, gain CE marking and FDA approvals an...
|